Company intelligence / Profile preview

VivaQuant

Saint Paul / Arden Hills / St. Paul area, Minnesota, United Statesrhythmexpressecg.com ↗

Ownership: Private
Development stage: Commercial

Overview

VivaQuant provides commercial remote cardiac monitoring services using its proprietary Rhythm Express RX‑1 mini device, which leverages advanced signal processing to deliver high-fidelity ECG data for accurate arrhythmia detection. The system has been used in over 160,000 patients and is recognized for its innovation in digital health.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware/algorithmic analysis (for ECG data)
Industry: Physiological Monitoring

Partnerships

Data Sciences International (DSI): partnership to integrate VivaQuant’s software with DSI’s preclinical telemetry systems for research applications

Beyond the preview

Go deeper on VivaQuant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VivaQuant.

Explore the full profile